Most men looking into a new erectile dysfunction treatment are not starting from zero. They have already filled a prescription for sildenafil or tadalafil, taken it the way the label says, and watched it work well at first and then less well, or found that it never did much at all. The real decision is not which new option sounds most advanced, because the honest answer changes depending on why the pill is underperforming. Blood flow, hormones, nerve signaling, and anxiety all produce the same complaint in the bedroom and call for completely different treatment, which is why two men who both say the pills stopped working can need opposite plans.
Erectile dysfunction is not a niche problem. The clinical review Latest treatment for erectile dysfunction: What’s new? puts the number of affected men in the United States at roughly 30 to 50 million, and the options available to them now extend well past the oral medications of the last twenty-five years to include shockwave therapy, injection therapy, an over-the-counter topical gel, combination regenerative protocols, and better imaging to sort out who belongs in which category. What follows compares those options against the pills you have already tried, and against each other, with the diagnosis doing the deciding.
Why Oral PDE5 Inhibitors Stop Working for Some Men
PDE5 inhibitors do not create an erection; they protect the signaling chemistry that produces one, which means they amplify a response your body still has to be capable of generating. Arousal has to trigger nitric oxide release, the endothelium lining the penile arteries has to respond, and those arteries have to be able to dilate and hold pressure. When years of hypertension, diabetes, smoking, or high cholesterol have narrowed and stiffened the inflow vessels, the drug has less to amplify, and moving from a low dose to the maximum dose does not rebuild an artery. One 2026 review of newer ED treatments describes the pattern in the men most likely to be disappointed by pills: Men with arterial ED often report difficulty achieving firm erections despite adequate desire.
Hormones create a second, quieter failure mode. Testosterone supports nitric oxide synthase activity, so when levels fall, the tissue produces less of the signal a PDE5 inhibitor is designed to preserve, and the same prescription that worked at forty can feel inconsistent and unpredictable a few years later. Men in that situation often assume they need a stronger drug when what they need is a testosterone panel, because correcting a genuine deficiency can change how the pill performs and is worth knowing before paying for anything more involved.
Not every non-response points at the vasculature, and that distinction matters more than any product comparison. Psychogenic ED tends to be situational and often responds to medication when the underlying anxiety is addressed alongside it, while neurogenic ED following pelvic surgery, spinal injury, or diabetic neuropathy fails because the arousal signal never reaches the tissue in the first place. A pill that stops working is useful information, but only if someone interprets it.
Diagnosing the Root Cause Before Choosing a New Treatment
The single most useful step after a pill plateau is imaging the blood flow rather than guessing at it. Penile duplex ultrasound, also called a penile Doppler study, is characterized in that same 2026 review as one of the most valuable diagnostic tools in an ED evaluation, and its value is practical: it shows whether blood is failing to arrive because the arteries cannot deliver it, or arriving normally and escaping through a venous leak. Those two findings lead to different treatment. Mild to moderate arterial insufficiency is exactly the profile that regenerative vascular treatment targets, whereas a significant venous leak means the problem is retention rather than inflow, and a therapy aimed at improving arterial supply addresses only part of what is wrong.
Labs belong in the same visit as the imaging. A hormonal panel that includes total and free testosterone either rules low testosterone out as a contributor or identifies it as a correctable one, and there is little sense in committing to a course of vascular treatment while an untreated endocrine deficit is still degrading the response. Because erectile dysfunction can surface as an early marker of systemic vascular disease, a thorough workup also considers cardiovascular and metabolic risk instead of treating the symptom in isolation.
Compare that with a symptom questionnaire filled out online followed by a shipped prescription. There is nothing wrong with a supervised pill trial as a first step, but repeating a treatment that has already failed through a faster checkout is not a plan, and no questionnaire can tell you whether your arteries or your hormones are the limiting factor. Boston Vitality’s care model includes testing, diagnosis, and follow-up monitoring, with treatment plans personalized around symptoms, labs, lifestyle, and goals, which is the sequence that makes the newer options worth evaluating at all.
Shockwave Therapy Versus Pills for Vasculogenic ED
Low-intensity extracorporeal shockwave therapy, usually shortened to Li-ESWT, works on a different premise than anything in a pill bottle. Acoustic pulses delivered to penile tissue are intended to stimulate neovascularization, meaning the growth of new microvasculature, rather than temporarily widening the vessels you already have for a few hours at a time. The comparison with oral medication is therefore not apples to apples: a PDE5 inhibitor manages the symptom on demand and leaves the underlying arterial supply exactly as it was, while a shockwave course aims at the supply itself. That difference shows up in duration of benefit, and the 2026 review is direct about it, noting that Recent studies indicate that shockwave therapy offers sustained benefits for up to 30 months in the right candidates.
The right candidate is a narrower group than the marketing around these devices suggests. The evidence supports mild to moderate vasculogenic ED, which is why duplex ultrasound matters before booking sessions rather than after. Men with severe arterial disease, an existing penile implant, or ED driven by nerve injury or psychological factors are poor fits, and results vary between individuals even within the appropriate group, so no clinic can promise a specific outcome from a protocol.
Access and cost run the other direction. A generic PDE5 inhibitor is a refill that costs little, requires no appointments, and is usually covered in some form, while Li-ESWT means a course of multiple sessions over several weeks, generally paid out of pocket because insurers rarely cover it. My recommendation for a man with duplex confirmed mild to moderate arterial insufficiency who still gets a partial response to pills is to treat shockwave as the leading new option rather than the last resort, and to understand that the two are not mutually exclusive; improving inflow can make an oral medication work better than it did before.
Trimix Injections When Oral Medications Have Failed
Trimix is a compounded combination of vasoactive medications injected directly into the corpus cavernosum, and its advantage is mechanical rather than subtle. Where a PDE5 inhibitor depends on your own nitric oxide signaling to start the process, Trimix relaxes cavernosal smooth muscle directly through more than one pathway, so it can produce a usable erection in men whose vascular architecture or nerve supply is too compromised for pills to do anything at all. Complete non-response to oral medication, which ends the conversation with a lot of prescribers, is not a barrier here.
The trade-offs are real and worth stating plainly. Trimix requires you to inject yourself before sex, which some men accept quickly, and others never do, and it requires dose titration that starts low and moves up under supervision because the effective dose differs considerably from one man to the next. Priapism, a prolonged erection that becomes a medical emergency, is the risk that makes physician oversight non-negotiable: the first doses should be given and observed in a clinical setting, you should leave with explicit instructions on when to seek emergency care, and no one should be self-administering a dose that was never titrated for them.
Handled that way, injection therapy is the most dependable non-surgical option for men with advanced vascular disease who have exhausted the oral route. It is a step up in commitment from swallowing a tablet, and men who reject it usually reject the needle rather than the results.
Eroxon Topical Gel and Where It Fits
Eroxon, also identified as MED3000, is a topical gel approved by the FDA for the treatment of ED in men aged 22 and older, sold over the counter in single-use tubes and intended to increase blood flow to the penis. Its appeal is obvious to anyone who has put off a medical appointment: no prescription, no needle, no session schedule, and no conversation required to obtain it.
The same convenience is the caveat. Buying a treatment off a shelf means nobody has looked at your testosterone, your metabolic markers, or your penile blood flow, and because erectile dysfunction can be the first visible sign of systemic vascular disease, quietly managing the symptom for a year can delay a diagnosis that matters well beyond sex. The published evidence base behind it is also considerably thinner than the decades of data behind oral PDE5 inhibitors. As a practical verdict, Eroxon is a reasonable choice for mild, occasional, or situational difficulty, or for a man who cannot or prefers not to take an oral medication, but it is not a substitute for a workup once pills have already failed repeatedly.
Li-ESWT Combined With PRP Therapy
Platelet-rich plasma is prepared from a man’s own blood and concentrated to deliver growth factors into the treated tissue, and the logic of pairing it with shockwave is that the acoustic pulses create the stimulus while the PRP supplies additional biological material at the same site. There is direct support for the combination: the review New Treatment Modalities for Erectile Dysfunction reports a 2024 study in which Li-ESWT combined with PRP produced superior results compared with Li-ESWT alone.
Read that finding for what it is. It supports PRP as an addition to a shockwave protocol, not as a standalone ED treatment, where the evidence remains unsettled, and a single study does not establish the optimal number of sessions, injection timing, or preparation method. Practically, the combination requires a clinic that offers both modalities, availability varies by market, and the cost sits above a single modality shockwave course. If you are already committed to a shockwave course, it is worth asking what the added expense buys and whether the clinic follows a defined protocol rather than improvising one.
Candidacy, Sequencing, and What Happens When New Treatments Fall Short
Sequencing is where most men lose time and money, usually by shopping for the newest modality before anyone has established which one their diagnosis calls for. A pill plateau should trigger a root cause workup, and the results of that workup, meaning duplex imaging plus hormonal labs, decide whether the next step is vascular treatment, injection therapy, or hormonal correction. If labs show low testosterone, addressing the hormonal deficit first is the more logical order, since restoring the signaling environment may improve how the oral medication performs and can spare you the cost of a device course; testosterone therapy carries its own considerations around fertility, cardiovascular and metabolic health, and eligibility, so it belongs in a physician evaluation rather than a same-day purchase.
When vasculogenic ED is confirmed and a shockwave course does not produce meaningful change, the escalation path is reasonably clear. Injection therapy is the next line, and for men who fail or cannot tolerate injections, a surgical consultation about a penile implant is the durable option and should be presented as such rather than treated as a failure. Neurogenic and psychogenic cases follow a different route entirely; a man with ED after pelvic surgery may be a candidate for injections without ever benefiting from a regenerative protocol, and a clearly situational pattern will not be solved by any device no matter how new it is.
Verdicts by Situation and What a Consultation Covers
- Duplex confirmed mild to moderate arterial ED with partial pill response: Li-ESWT is the strongest new option, with PRP worth discussing as an add on.
- Complete non-response to oral medication with advanced vascular disease: injection therapy with supervised dose titration.
- Low testosterone identified on labs alongside ED: correct the hormonal picture and reassess the oral medication before committing to a device course.
- Mild, occasional, or situational difficulty, or an oral medication you cannot take: Eroxon as an over the counter option, with a workup still on the table.
- ED following pelvic surgery or nerve injury, or a clearly situational pattern: a different clinical pathway, though labs and imaging remain worth running.
A consultation worth your time should look like the sequence above rather than a symptom checklist: a full history, labs that include hormones, imaging where the presentation warrants it, a plan that names the diagnosis before it names the treatment, and monitoring that tells you whether the plan is working. Boston Vitality’s team specializes in testosterone optimization, ED treatment, medical weight loss, and performance restoration, and its treatment plans are built around symptoms, labs, lifestyle, and goals, with testing, diagnosis, and follow up monitoring included in the care rather than sold separately. If the pills have stopped doing their job, schedule your consultation and find out what is actually driving it.
TL;DR: Men who find that sildenafil or tadalafil has stopped working or never worked well need a root-cause diagnosis first, because newer options such as shockwave therapy, injection therapy, and topical gels each target different mechanisms and no single upgrade fits every patient.